Industry News (Hormone Replacement Therapy)

FDA Approves Smallest Transdermal Estrogen Delivery System

Published in Women's Health Weekly, January 18th, 1999

Noven Pharmaceuticals, Inc. announced that its second generation transdermal estrogen delivery system (transdermal 17(beta)-estradiol) has been approved by the U.S. Food and Drug Administration for the treatment of the symptoms of menopause.

The new product, developed and manufactured by Noven, is the smallest transdermal estrogen patch ever approved. The patch is expected to be marketed and sold in the U.S. by Vivelle Ventures LLC, a women's health products company jointly owned by Noven and Novartis Pharmaceuticals Corporation, beginning in the first half of 1999.

Slightly larger than a nickel, the patch is less than half the size of any other...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (1999-01-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry